Since the turn of the 20th century Bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer (NMIBC) has been in and out of favour. However, only a small proportion of patients, as low as 16%, complete what is seen as a gold standard treatment. To understand why ...
At present, BCG intravesical instillation therapy is considered a very effective treatment modality for superficial bladder cancer. In this paper, the present status of BCG intravesical treatment was discussed along with speculation on the future directions of BCG treatment for this malignant disease....
Bladder cancer experts discuss the evolving treatment landscape in BCG-unresponsive NMIBC and give an overview of TAR-200, an emerging therapy.This is a modal window. This video is either unavailable or not supported in this browserError Code: MEDIA_ERR_SRC_NOT_SUPPORTEDTechnical details : The...
To explore whether intravesical chemotherapy (IVC) between primary and second transurethral resection of bladder tumor (TURBT) affects the prognosis of non-muscle invasive bladder cancer (NMIBC) patients receiving Bacillus Calmette-Gu茅rin (BCG) treatment. NMIBC patients who underwent a second TURBT ...
aIt doesn’t have to be that way. 它不必须是那个方式。[translate] aEffect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: A systematic review. 抗凝剂和antiplatelet代理的作用在膀胱癌的intravesical BCG治疗效力: 系统的回顾。[translate]...
In this mini-review, we discuss how nanotechnology can help overcome current obstacles in bladder cancer treatment, and how nanotechnology can facilitate combination chemotherapeutic and BCG immunotherapies for the treatment of non-muscle invasive urothelial bladder cancer. 展开 ...
Bacillus Calmette-Gu茅rin (BCG) is the primary method of postoperative perfusion treatment for bladder cancer. The myeloid cell leukemia gene-1 (Mcl-1) is closely associated with the development of malignant tumors. Previous research by our group has demonstrated that downregulatingMcl-1using shRNA...
Herein, we examined the use of BCG vaccine treatment in patients with NMIBC and the risk of death and dementia. To our knowledge, we present the largest-to-date population health study of intravesical BCG vaccine for bladder cancer and ADRD, using electronic health records from patients ...
Nanocrystal's Formulation of Biological Response Modifier P-MAPA on Bladder Cancer Compared to Bacillus Calmette-Guerin Immunomodulator that this new nanoformulation of P-MAPA in the presence of Pluronic F68 could be a potential candidate for treatment of in vivo bladder cancer.doi... WJ Fvaro,AC...
目的:探讨卡介苗膀胱灌注对保留膀胱术后反复复发的膀胱移行细胞癌患者预防复发和进展的疗效。方法:对3例膀胱癌患者进行卡介苗灌注治疗的临床资料进行回顾性分析。结果:3例患者保留膀胱术后经卡介苗膀胱灌注治疗,复发率明显降低,进展减缓。结论:卡介苗膀胱灌注能够有效